Dr. Freeze is an analytical chemist and credits his undergraduate chemistry teaching degree as a critical part of his training that helped him understand how to relate to people effectively and become an impactful leader in business. Ron has over 25 years of experience in industry spanning biologics, pharmaceuticals, devices, and diagnostics. A highlight of his time in the R&D labs was developing a new formulation for ritonavir, a drug that is a cornerstone in the global fight against AIDS. When reports of a solid being seen in ritonavir liquid started coming in from around the world, it was determined that a new crystal form that was more stable and much less soluble had emerged, making the formulation useless for patients and interrupting the global supply of AIDS treatments. At the time this had the biggest impact on African nations that were being ravaged by AIDS, had limited treatment options and underdeveloped healthcare systems. Ron and his team were the central R&D lab charged with developing a new formula in record time to minimize the impact of this new crystal form.
Dr. Freeze continued his role in healthcare in regulatory, having the opportunity to lead global teams and working with authorities around the world to develop regulatory frameworks that focused on patient health. He was especially busy during the COVID outbreak, working with companies and the FDA to develop new diagnostic tools to effectively detect the spread of the virus. He has continued working in the consulting space focused on the quickly advancing MedTech area that is pairing AI with devices to reduce errors and further expand the options for patients.
B.A., Chemistry Education, University of Northern Iowa; Ph.D., Analytical Chemistry, Iowa State University
Multiple training modules for the Regulatory Affairs Professional Society including:
Undergraduate: B.A in Chemistry Education, University of Northern Iowa, 1991
Graduate: Ph.D. in Analytical Chemistry, Iowa State University University, 1997
Post Graduate: Regulatory Affairs Certification, Regulatory Affairs Professionals Society, 2015
Many of the chelating resins used in the past for preconcentration of metal cations have been relatively inefficient. More effective resins can be created by careful attention to the particle size and physical structure of the resin, its chelating capacity, and the selectivity and kinetics of the chelating groups present in the resin.
Through the hard work and dedication of a group of subject matter experts, this Framework was developed to improve IVD innovation, reduce inefficient use of costly biological test materials, and ultimately improve timely patient access to safe and effective IVDs.
Multiple training modules for the Regulatory Affairs Professional Society including:
Sunny skies, warm temperatures, a beautiful campus. What more could you want? How about a community-like atmosphere, quality instructors who care about your success, a wealth of spiritual activities, expert career guidance… and that’s only the beginning. Imagine your future at AMU. It all starts by filling out our free application today.
APPLY NOW5050 Ave Maria Blvd., Ave Maria, FL 34142
